Clin2
NCT07220408Possibly a fitRecruiting

TL-925 eye drops for seasonal eye allergies

Allergic Conjunctivitis

Part of Eyes & vision, Immune system & allergy clinical trials.

This trial tests an investigational eye drop called TL-925 for people with seasonal allergic conjunctivitis (eye allergies triggered by pollen, grass, etc.). It aims to see if TL-925 can relieve symptoms like redness and itching.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
60 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have a history of eye allergies and a positive allergy skin test to seasonal or year-round allergens
  • You are not currently pregnant, and if you or your partner can become pregnant, you agree to use effective birth control during the study
  • You have not had any eye surgery in the last 3 months or laser vision correction in the last 6 months
  • You do not have any eye infection or other eye condition that could interfere with the study results

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06686472Recruiting· Phase 2
Testing TL-925 eye drops for allergic conjunctivitis

This trial tests an investigational eye drop called TL-925 to see if it can treat allergic conjunctivitis (eye allergies). If you have a history of eye allergies and a positive allergy skin test, you may be able to join.

Memphis, Tennessee
NCT07805759Recruiting
Triple action eye drops for allergy symptoms

This trial tests an eye drop called Daydrop Triple Action to see if it helps with eye itching and redness caused by allergies. It might be a good option if you have allergic conjunctivitis and have not used other allergy eye medications recently.

Madrid, Madrid
NCT07395232Recruiting· Phase 3
Treatment for allergic eye disease

This trial tests a new eye drop to reduce itching and other symptoms of allergic conjunctivitis, a condition where the eyes become red, itchy, and uncomfortable due to allergies. It may help people who have not found relief with current treatments.

Jacksonville, Florida
NCT07740564Recruiting· Phase 3
Study of an eye drop for moderate to severe dry eye

This study tests an investigational eye drop called OT202 to see if it helps people with moderate to severe dry eye. If you join, you'll receive either the study drug or a placebo (no active ingredient) and have your symptoms and eye health monitored for several months.

Bengbu, Anhui
NCT07273747Recruiting
Kelulut honey for eye allergy and dry eye

This study tests if Kelulut honey eye drops can help people with both allergic conjunctivitis (eye allergies) and dry eye symptoms. If you have been diagnosed with eye allergies and still have bothersome symptoms despite treatment, this trial may offer a natural option to explore.

Kota Bharu, Kelantan
NCT07219849Recruiting· Phase 2
Testing a new nasal spray for seasonal allergies

This study tests a new nasal spray (ALDP001) in adults with seasonal allergies to ragweed. It aims to find the best dose and how often to use it.

Mississauga, Ontario

Hear when a new Allergic Conjunctivitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.